Initial studies have shown that p21 inhibits initiator apoptotic caspase cleavage by TNF-related apoptosis-inducing ligand (DR4/TRAIL) receptor, thus suppressing apoptosis and enhancing survival of human breast and colon cancer cells [139]. The gene discussed is CDKN1A; the disease is malignant colon neoplasm.